GLP‑1 side effects (US): what to expect on Wegovy, Zepbound, Ozempic, or Mounjaro

ByGLP1-Consultant

TL;DR

  • Most people experience some gastrointestinal side effects, especially early on and after dose increases.
  • The most common symptoms are nausea, diarrhea, constipation, vomiting, abdominal discomfort, and reflux/indigestion.
  • Side effects are often dose-related and can improve when the body adjusts, but severe symptoms are not something to ignore.
  • Serious risks discussed in FDA labeling include pancreatitis, gallbladder disease, kidney problems (often from dehydration), and allergic reactions.
  • These medications have a boxed warning about thyroid C‑cell tumors and are contraindicated for people with MTC/MEN2.

Key takeaways

  • Many patients can stay on therapy with the right plan: slow titration, hydration, and early communication.
  • The most important safety skill is recognizing red-flag symptoms.
  • If you’re using compounded products, dosing errors can greatly increase side effects. Read Compounded semaglutide/tirzepatide safety.

Short answer

GLP‑1 and dual-incretin medications commonly cause nausea, diarrhea, constipation, vomiting, and stomach discomfort—especially when starting treatment or increasing the dose. Most symptoms are manageable, but patients should know warning signs of serious problems like pancreatitis (severe, persistent abdominal pain), gallbladder disease, dehydration, or allergic reactions. Always follow your prescriber’s titration plan and seek urgent medical care for severe symptoms.

Which medications are included?

In the U.S., patients often mean one of these prescriptions:

  • Wegovy® (semaglutide) — chronic weight management
  • Zepbound® (tirzepatide) — chronic weight management
  • Ozempic® (semaglutide) — type 2 diabetes (sometimes used off-label for weight)
  • Mounjaro® (tirzepatide) — type 2 diabetes

Helpful comparisons:

Why GLP‑1 medicines cause GI side effects

These medications influence appetite and digestion. Depending on the drug and dose, they can:

  • slow stomach emptying (especially early in therapy)
  • reduce hunger signals
  • change how quickly and how much you eat

That can create a mismatch between your usual meal patterns and what your body tolerates, leading to nausea, reflux, or constipation.

A common pattern patients report:

  • worse symptoms after injections or dose increases
  • gradual improvement as the body adapts

Common side effects (what they feel like)

1) Nausea

Nausea may feel like:

  • a “car-sick” sensation
  • food aversion
  • feeling full after just a few bites

Common triggers patients mention:

  • large meals
  • high-fat foods
  • eating quickly
  • alcohol

2) Constipation

Constipation can happen because:

  • you’re eating less volume and less fiber
  • you’re drinking less water
  • motility changes

Constipation can contribute to nausea and abdominal discomfort, so it’s worth mentioning early.

3) Diarrhea

Diarrhea may occur:

  • early in treatment
  • around dose increases
  • if your diet suddenly changes (more sugar alcohols, high-fat meals, etc.)

4) Vomiting

Vomiting is more likely when nausea becomes severe, and it can quickly cause dehydration.

5) Reflux / indigestion / “sulfur burps”

Some patients report reflux-like symptoms or unpleasant burps. These can be diet- and timing-related.

6) Reduced appetite (desired effect, but can become a problem)

Appetite reduction is part of how these drugs help. But if you’re unable to eat enough to stay hydrated and nourished, you may feel:

  • fatigue
  • dizziness
  • headaches

Discuss persistent issues with your clinician.

Serious side effects and warning signs (don’t ignore these)

This section is intentionally repetitive—because recognizing these symptoms can be important.

Possible pancreatitis

Seek urgent medical evaluation for:

  • severe, persistent abdominal pain (may radiate to the back)
  • pain with vomiting
  • pain that does not improve

Gallbladder problems (gallstones, inflammation)

Possible signs include:

  • right upper abdominal pain (especially after eating)
  • fever
  • nausea/vomiting that doesn’t settle
  • yellowing of the skin/eyes (jaundice)

Dehydration and kidney injury

Dehydration risk rises when vomiting/diarrhea is significant.

Watch for:

  • inability to keep fluids down
  • dizziness/fainting
  • very dark urine or urinating much less

Severe allergic reaction

Call 911 for:

  • trouble breathing
  • swelling of face/lips/tongue
  • widespread hives

Boxed warning: thyroid C‑cell tumors (MTC/MEN2)

GLP‑1 and dual-incretin drugs used for weight management carry a boxed warning based on rodent studies. They are contraindicated in patients with:

  • personal or family history of medullary thyroid carcinoma (MTC)
  • Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

If you have thyroid nodules or a thyroid history, ask your clinician how this warning applies to you.

When do side effects usually happen?

Many patients notice side effects:

  • at the beginning (first few doses)
  • after a dose increase
  • sometimes 24–72 hours after an injection

Everyone is different. Some people feel side effects the same day; others feel them later in the week.

How clinicians often approach side-effect management (education, not instructions)

Your prescriber may consider strategies like:

Slower titration

If symptoms are limiting, clinicians may:

  • delay a dose increase
  • temporarily return to a prior dose

Symptom-focused support

Depending on your medical history, they may recommend:

  • hydration strategies (sometimes electrolytes)
  • constipation treatments
  • anti-nausea medication

Do not add OTC treatments without asking if you have other conditions or take other medications.

Meal pattern adjustments

Many clinicians encourage a pattern like:

  • smaller portions
  • slower eating
  • avoiding very high-fat meals during titration

The right approach depends on you.

Special situations to discuss with your clinician

If you have diabetes

If you take insulin or sulfonylureas, your clinician will consider hypoglycemia risk and glucose monitoring.

If you have kidney disease

Vomiting/diarrhea can be more risky due to dehydration.

If you have a history of pancreatitis or gallbladder disease

Bring this up before starting.

If you’re planning pregnancy

Weight-loss medications are generally avoided in pregnancy; timing and washout periods are clinician-guided.

If you’re having surgery or a procedure requiring anesthesia

Because these drugs can affect gastric emptying, anesthesia teams sometimes have specific pre-procedure instructions. Tell your surgical team you’re taking a GLP‑1/dual-incretin medication.

If you’re using compounded products

Compounded products can increase risk of side effects because:

  • concentration may vary
  • dosing is manual (vials/syringes)
  • errors can lead to a much higher-than-intended dose

Read: Compounded semaglutide/tirzepatide safety.

FAQ

How long do GLP‑1 side effects last?

Many people feel the worst symptoms early on and after dose increases. For some, symptoms improve over weeks; others need a different titration plan or a different medication.

Why do I feel tired?

Fatigue can be related to reduced calories, dehydration, or poor sleep during nausea. Persistent fatigue should be discussed with your clinician.

What should I do if I’m vomiting?

If vomiting is severe or you can’t keep fluids down, seek medical attention. Dehydration can become serious.

Should I stop the medication if I have nausea?

Do not stop or change dosing without guidance unless you have emergency symptoms. Contact your prescriber to discuss next steps.

References

Medical disclaimer

This article is for general educational purposes only and does not provide medical advice. Always consult a licensed clinician for individualized guidance, especially if you have severe symptoms or other medical conditions. For emergencies, call 911.